Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.

Liu G, Wheatley-Price P, Zhou W, Park S, Heist RS, Asomaning K, Wain JC, Lynch TJ, Su L, Christiani DC.

Int J Cancer. 2008 Feb 15;122(4):915-8.

2.

Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer.

Lind H, Zienolddiny S, Ekstrøm PO, Skaug V, Haugen A.

Int J Cancer. 2006 Aug 1;119(3):718-21.

3.

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.

Dong J, Ren B, Hu Z, Chen J, Hu L, Dai J, Jin G, Xu L, Shen H.

Mol Carcinog. 2011 Jun;50(6):433-8. doi: 10.1002/mc.20727. Epub 2011 Jan 25.

PMID:
21268124
4.

Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.

Chien WP, Wong RH, Cheng YW, Chen CY, Lee H.

Ann Surg Oncol. 2010 Apr;17(4):1194-202. doi: 10.1245/s10434-009-0853-2. Epub 2009 Nov 26.

PMID:
19941079
5.
6.

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, Wang Y, Lin D.

Hum Mutat. 2006 Jan;27(1):110-7.

PMID:
16287156
7.

Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.

Han JY, Lee GK, Jang DH, Lee SY, Lee JS.

Cancer. 2008 Aug 15;113(4):799-807. doi: 10.1002/cncr.23668.

8.

Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.

Chua HW, Ng D, Choo S, Lum SS, Li H, Soh LY, Sabapathy K, Seow A.

BMC Cancer. 2010 Mar 10;10:88. doi: 10.1186/1471-2407-10-88.

9.

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.

Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.

Clin Cancer Res. 2007 Jul 15;13(14):4123-9.

10.

Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.

Zheng D, Chen Y, Gao C, Wei Y, Cao G, Lu N, Hou Y, Jiang X, Wang J.

Cancer Biol Ther. 2014;15(11):1542-51. doi: 10.4161/15384047.2014.956599.

11.

Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis.

Bai J, Dai J, Yu H, Shen H, Chen F.

J Toxicol Environ Health A. 2009;72(11-12):677-82. doi: 10.1080/15287390902840930.

PMID:
19492228
12.

Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck.

Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG, Wei Q.

Mol Carcinog. 2011 Sep;50(9):697-706. doi: 10.1002/mc.20806. Epub 2011 Jun 7.

13.

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.

Yoneda T, Kuboyama A, Kato K, Ohgami T, Okamoto K, Saito T, Wake N.

Oncol Rep. 2013 Jul;30(1):25-34. doi: 10.3892/or.2013.2433. Epub 2013 Apr 29.

14.

Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene.

Mittelstrass K, Sauter W, Rosenberger A, Illig T, Timofeeva M, Klopp N, Dienemann H, Meese E, Sybrecht G, Woelke G, Cebulla M, Degen M, Morr H, Drings P, Groeschel A, Kreymborg KG, Haeussinger K, Hoeffken G, Schmidt C, Jilge B, Schmidt W, Ko YD, Taeuscher D, Chang-Claude J, Wichmann HE, Bickeboeller H, Risch A.

BMC Cancer. 2008 Apr 23;8:113. doi: 10.1186/1471-2407-8-113.

15.

GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.

Schneider J, Bernges U, Philipp M, Woitowitz HJ.

Cancer Lett. 2004 May 10;208(1):65-74.

PMID:
15105047
16.

p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.

Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C, Xu W, Marshall AL, Heist RS, Wain JC, Lynch TJ Jr, Christiani DC, Liu G.

Clin Cancer Res. 2009 May 1;15(9):3103-9. doi: 10.1158/1078-0432.CCR-08-3120. Epub 2009 Apr 21.

17.

Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.

Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P.

Lung Cancer. 2007 Jan;55(1):25-34. Epub 2006 Oct 23.

PMID:
17059853
18.

[Genetic polymorphism in MDM2 is associated with susceptibility to colorectal cancer in a Chinese population].

Liu JN, Zhang XM, Guo YL, Sun T, Lin DX, Wen T.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):335-8. Chinese.

PMID:
18953830
19.

Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.

Butkiewicz D, Popanda O, Risch A, Edler L, Dienemann H, Schulz V, Kayser K, Drings P, Bartsch H, Schmezer P.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2242-6.

20.

MDM2 polymorphism, survival, and histology in early-stage non-small-cell lung cancer.

Heist RS, Zhou W, Chirieac LR, Cogan-Drew T, Liu G, Su L, Neuberg D, Lynch TJ, Wain JC, Christiani DC.

J Clin Oncol. 2007 Jun 1;25(16):2243-7.

Items per page

Supplemental Content

Write to the Help Desk